Analgesic triptan action in an animal model of intracranial pain: A race against the development of central sensitization
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
We have shown that the development of cutaneous allodynia (exaggerated skin sensitivity) during migraine is detrimental to the anti‐migraine action of the 5HT IB/ID receptor agonists known is triptans. Because cutaneous allodynia is a manifestation of sensitization of central trigeminovascular neurons, we examined whether triptan treatment can intercept such sensitization before its initiation or after its establishment in our rat model for cutaneous allodynia induced by intracranial pain. Single‐unit recordings were obtained from spinal trigeminal neurons that proved to received convergent inputs from the dura and facial skin. The effects of sumatriptan (300 μg/kg i.v.) on central sensitization induced by topical application of inflammatory soup (IS) on the dura were determined when the drug was administered either 2 h after IS (late intervention) or at the same time as IS (early intervention). Late sumatriptan intervention counteracted two aspects of central sensitization: dural receptive fields, which initially expanded by IS, shrunk back after treatment; neuronal response threshold to dural indentation, which initially decreased after IS, increased after sumatriptan. On the other hand, late sumatriptan intervention did not reverse other aspects of central sensitization: spontaneous firing rate and neuronal response magnitude to skin brushing which initially increased after IS, remained elevated after sumatriptan; response threshold to heating of the skin, which initially dropped after IS, remained low after sumatriptan. Early sumatriptan intervention effectively blocked the development of all aspects of central sensitization expected to be induced 2 h after IS application: dural receptive fields did not expand; neuronal response threshold to dural indentation and skin stimulation did not decrease; spontaneous firing rate did not increase. The early treatment results suggest that triptan action provides a powerful means of preventing the initiation of central sensitization triggered by chemical stimulation of meningeal nociceptors. The late treatment results suggest that triptan action is insufficient to counteract an already established central sensitization. Thus, triptan action appears to be exerted directly on peripheral rather than central trigeminovascular neurons. Ann Neurol 2004;55:000–000
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Nonparametric Statistics for the Behavioral Sciences
Furfey, P. H., & Siegel, S. (1957) · The American Catholic Sociological Review · doi:10.2307/3708383 · Cited by 1,362
Goadsby, P. J., & Edvinsson, L. (1993) · Annals of Neurology · doi:10.1002/ana.410330109 · Cited by 1,158
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor-Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<614::aid-ana9>3.0.co;2-n · Cited by 1,016
Self-citationBurstein, R. (2000) · Brain · doi:10.1093/brain/123.8.1703 · Cited by 763
Self-citationSensitization of meningeal sensory neurons and the origin of headaches
Strassman, A. M., Raymond, S. A., & Burstein, R. (1996) · Nature · doi:10.1038/384560a0 · Cited by 703
Self-citationBurstein, R., Yamamura, H., Malick, A., & Strassman, A. M. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.964 · Cited by 606
Self-citationDefeating migraine pain with triptans: A race against the development of cutaneous allodynia
Burstein, R., Collins, B., & Jakubowski, M. (2004) · Annals of Neurology · doi:10.1002/ana.10786 · Cited by 602
Self-citationSteen, K., Reeh, P., Anton, F., & Handwerker, H. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-01-00086.1992 · Cited by 487
Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
Moskowitz, M. A. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90097-p · Cited by 430
Cited by
Central sensitization: a generator of pain hypersensitivity by central neural plasticity
Latremoliere, A., & Woolf, C. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.012 · Cited by 3,913
Migraine: Multiple Processes, Complex Pathophysiology
Burstein, R., Noseda, R., & Borsook, D. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0373-15.2015 · Cited by 838
Self-citationIyengar, S., Ossipov, M. H., & Johnson, K. W. (2017) · Pain · doi:10.1097/j.pain.0000000000000831 · Cited by 584
A neural mechanism for exacerbation of headache by light
Noseda, R., Kainz, V., Jakubowski, M., Gooley, J. J., Saper, C. B., Digre, K., & Burstein, R. (2010) · Nature Neuroscience · doi:10.1038/nn.2475 · Cited by 565
Self-citationCGRP and the Trigeminal System in Migraine
Iyengar, S., Johnson, K. W., Ossipov, M. H., & Aurora, S. K. (2019) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13529 · Cited by 486
Migraine: Epidemiology, Impact, and Risk Factors for Progression
Lipton, R. B., & Bigal, M. E. (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.4501001.x · Cited by 417
Zhang, X., Levy, D., Noseda, R., Kainz, V., Jakubowski, M., & Burstein, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0511-10.2010 · Cited by 408
Self-citationModifiable risk factors for migraine progression
Bigal, M. E., & Lipton, R. B. (2006) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00577.x · Cited by 334
Bernstein, C., & Burstein, R. (2012) · Journal of Clinical Neurology · doi:10.3988/jcn.2012.8.2.89 · Cited by 327
Self-citationMigraine as an inflammatory disorder
Waeber, C., & Moskowitz, M. A. (2005) · Neurology · doi:10.1212/wnl.64.10_suppl_2.s9 · Cited by 321
Obesity is a risk factor for transformed migraine but not chronic tension-type headache
Bigal, M. E., & Lipton, R. B. (2006) · Neurology · doi:10.1212/01.wnl.0000225052.35019.f9 · Cited by 308
Orofacial pain management: current perspectives
Romero-Reyes, M., & Uyanik, J. M. (2014) · Journal of Pain Research · doi:10.2147/jpr.s37593 · Cited by 303
Amin, F. M., Asghar, M. S., Hougaard, A., Hansen, A. E., Larsen, V. A., de Koning, P. J., Larsson, H. B., Olesen, J., & Ashina, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70067-x · Cited by 295
Sumatriptan-Naproxen for Acute Treatment of Migraine: A Randomized Trial
Brandes, J. L., Kudrow, D., Stark, S. R., O’Carroll, C. P., Adelman, J. U., O’Donnell, F. J., Alexander, W. J., Spruill, S. E., Barrett, P. S., & Lener, S. E. (2007) · JAMA · doi:10.1001/jama.297.13.1443 · Cited by 276
Central Sensitization Theory of Migraine: Clinical Implications
Dodick, D., & Silberstein, S. (2006) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00602.x · Cited by 270
Levy, D., Jakubowski, M., & Burstein, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306147101 · Cited by 257
Self-citationA Systems Neuroscience Approach to Migraine
Brennan, K. C., & Pietrobon, D. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.029 · Cited by 245
“Triptans (5HT1b/d serotonin receptor agonists used in acute treatment) are more effective early in the attack, potentially because these peripherally-active agents have less effect once central sensitization has occurred(Burstein and Jakubowski, 2004; Burstein et al., 2004).”
Current practice and future directions in the prevention and acute management of migraine
Goadsby, P. J., & Sprenger, T. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70005-3 · Cited by 230
Medullary pain facilitating neurons mediate allodynia in headache‐related pain
Edelmayer, R. M., Vanderah, T. W., Majuta, L., Zhang, E., Fioravanti, B., De Felice, M., Chichorro, J. G., Ossipov, M. H., King, T., Lai, J., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21537 · Cited by 217
“Rats received dural administration of inflammatory mediators (IM) or synthetic interstitial fluid (SIF) and -CGRP(8-37) (0.”
BackgroundInfluentialMigraine: New Molecular Mechanisms
Pietrobon, D. (2005) · The Neuroscientist · doi:10.1177/1073858405275554 · Cited by 195
“However, late administration of sumatriptan, after establishment of central sensitization, only affected measures of central sensitization that depended on peripheral input from the meninges (such as the increased sensitivity to dural indentation) but not those independent of meningeal input (such as increased spontan…”
BackgroundMelo-Carrillo, A., Strassman, A. M., Nir, R.-R., Schain, A. J., Noseda, R., Stratton, J., & Burstein, R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2211-17.2017 · Cited by 189
“…the pain signals from the nociceptors, and accordingly, proposed that latephase central sensitization and allodynia explain the inferior efficacy of late treatment with drugs that lack the ability to reverse the sensitization(Burstein and Jakubowski, 2004; Burstein et al., 2004; Levy et al., 2004).”
BackgroundSelf-citationPathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies
Meng, I. D., Dodick, D., Ossipov, M. H., & Porreca, F. (2011) · Cephalalgia · doi:10.1177/0333102411402367 · Cited by 70
Metadata
- Authors
- Burstein, R., & Jakubowski, M.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2003-11-11
- Volume
- 55
- Issue
- 1
- Pages
- 27-36
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2166485517
- Cited by
- 357
- References
- 23
- FWCI
- 14.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.